Arkray Healthcare Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Arkray Healthcare Private Limited Pharmaceutical Export Portfolio Dataset — 3 Products, $9.6M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Arkray Healthcare Private Limited — Pharmaceutical Exporter Profile (2026) | 3 Products, $9.6M Trade | TransData Nexus

Arkray Healthcare Private Limited

Indian Pharmaceutical Exporter · Medical Devices & Diagnostics Specialist · $9.6M Total Trade · DGFT Verified

Arkray Healthcare Private Limited is an Indian pharmaceutical exporter with a total trade value of $9.6M across 3 products in 1 therapeutic categories. Based on 1,920 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Reagent ($3.3M), Diagnostic ($3.2M), Kit ($3.1M).

Arkray Healthcare Private Limited — Export Portfolio & Destination Treemap

Arkray Healthcare Private Limited pharmaceutical export portfolio — 3 products across 1 therapeutic categories. Source: Indian Customs (DGFT).

Who is Arkray Healthcare Private Limited? — Company Overview & Market Position

Arkray Healthcare Private Limited, incorporated on October 17, 2007, is a private company registered in Mumbai, Maharashtra, India. The company operates under the Corporate Identification Number (CIN) U51507MH2007PTC175112 and is classified as a non-government company. Its authorized share capital is ₹1,660,000,000, with a paid-up capital of ₹1,659,000,000. The registered office is located at 7th Floor, Opulence, 6th Road, TPS III, Santacruz East, Mumbai, Maharashtra 400055, India.

Arkray Healthcare Private Limited is a wholly owned subsidiary of ARKRAY Inc., Japan, which acquired the in vitro diagnostics (IVD) business of Span Diagnostics Limited. The company specializes in the research, development, manufacturing, distribution, and after-sales services of clinical testing instruments, reagents, and data management systems used for diagnosis, treatment, and medical examinations. Its product portfolio includes urine test strips, blood glucose systems, analyzers for diabetes testing, hematology testing, urinalysis, and lactate testing systems for athletes.

What Does Arkray Healthcare Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Reagent$3.3M

Product Portfolio — Top 3 by Export Value

Arkray Healthcare Private Limited exports 3 pharmaceutical products across 1 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Reagent	Medical Devices & Diagnostics	$3.3M	637	24.8%	2
2	Diagnostic	Medical Devices & Diagnostics	$3.2M	628	17.6%	2
3	Kit	Medical Devices & Diagnostics	$3.1M	655	0.7%	13

Arkray Healthcare Private Limited exports 3 pharmaceutical products across 1 therapeutic categories with a total export value of $9.6M. The top category is Medical Devices & Diagnostics (100.0% of portfolio), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Arkray Healthcare Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Arkray Healthcare Private Limited operates manufacturing facilities in Surat, Gujarat, India. The Surat plant specializes in the production of medical devices and diagnostic products, including urine test strips, blood glucose systems, and analyzers for diabetes testing. This facility supports the company's commitment to delivering high-quality diagnostic solutions to the Indian market and beyond.

3Key Leadership

The leadership team at Arkray Healthcare Private Limited comprises:

Yukitoshi Yao: Director since September 29, 2008.

Tadashi Inoue: Director since April 1, 2010.

Hiroshi Junichiro Hyodo: Director since January 31, 2017.

Kenji Yoshihara: Director.

Pankaj Kantilal Ajmera: Director.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Arkray Healthcare Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Arkray Healthcare Private Limited's products are subject to regulatory approvals in various international markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company has established a strong presence in these regions by obtaining necessary certifications and approvals for its diagnostic products. This includes compliance with the U.S. Food and Drug Administration (FDA) regulations, European Medicines Agency (EMA) standards, and other relevant regulatory bodies. The company's adherence to these standards ensures the safety and efficacy of its products in these markets.

2Emerging Markets

Arkray Healthcare Private Limited has expanded its reach into emerging markets across Africa, Latin America, and Southeast Asia. The company's products are prequalified by the World Health Organization (WHO), facilitating access to these regions. This prequalification enables the company to supply its diagnostic products to countries with stringent regulatory requirements, thereby enhancing its global footprint.

3Geographic Strategy

Arkray Healthcare Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Arkray Healthcare Private Limited's manufacturing facilities are registered with the U.S. Food and Drug Administration (FDA). The company has obtained approvals for its Abbreviated New Drug Applications (ANDAs) and Drug Master Files (DMFs), ensuring compliance with FDA standards. The facilities have undergone FDA inspections, which have been completed satisfactorily, confirming adherence to Good Manufacturing Practices (GMP). This compliance underscores the company's commitment to producing safe and effective diagnostic products for the U.S. market.

2WHO & EU GMP

Arkray Healthcare Private Limited's manufacturing facilities hold certifications from the World Health Organization (WHO) and comply with European Union Good Manufacturing Practices (EU GMP). These certifications affirm the company's commitment to maintaining high-quality manufacturing standards for its diagnostic products. The facilities are also listed in the European Directorate for the Quality of Medicines & HealthCare (EDQM) database, further validating their compliance with international quality standards.

3CDSCO & Indian Regulatory

Arkray Healthcare Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Arkray Healthcare Private Limited operates in a competitive landscape with several key players in the medical devices and diagnostics sector. Top competitors include companies such as Roche Diagnostics, Abbott Laboratories, and Siemens Healthineers. In the Indian market, Arkray Healthcare holds a significant position, with its top three products—Reagent, Diagnostic, and Kit—accounting for 24.8%, 17.6%, and 0.7% market share, respectively. This market share distribution indicates a strong presence in the diagnostic sector, with opportunities for growth in other product categories.

2Key Differentiators

Arkray Healthcare Private Limited's key differentiators include its comprehensive product portfolio, which spans various diagnostic categories, and its commitment to quality, as evidenced by certifications from WHO and EU GMP. The company's focus on customer support and sales and marketing has enabled it to serve over 100,000 customers and more than 2,000 healthcare professionals and hospitals across India. These strengths position the company as a reliable and customer-centric provider of diagnostic solutions.

3Strategic Position

Buyer Due Diligence Brief — Evaluating Arkray Healthcare Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Arkray Healthcare Private Limited has a strong track record in the diagnostics sector, with a total export value of $9.6 million USD and 1,920 shipments across three products in one therapeutic category. The company's portfolio concentration, with its top three products accounting for 42.9% of the market share, indicates a focused approach to product development and market penetration. The company's adherence to international quality standards and its commitment to customer satisfaction further enhance its reliability as a supplier.

2Certifications to Verify

Importers should verify the following certifications when considering Arkray Healthcare Private Limited as a supplier:

FDA Registration: Confirm the company's manufacturing facilities are registered with the U.S. Food and Drug Administration.

WHO-GMP Certification: Ensure the company holds certification from the World Health Organization's Good Manufacturing Practices.

Frequently Asked Questions — Arkray Healthcare Private Limited

How many pharmaceutical products does Arkray Healthcare Private Limited export from India?

Arkray Healthcare Private Limited exports 3 pharmaceutical products across 1 therapeutic categories. The top exports are Reagent ($3.3M), Diagnostic ($3.2M), Kit ($3.1M). Total export value is $9.6M.

What is Arkray Healthcare Private Limited's total pharmaceutical export value?

Arkray Healthcare Private Limited's total pharmaceutical export value is $9.6M, based on 1,920 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Arkray Healthcare Private Limited cover?

Arkray Healthcare Private Limited exports across 1 therapeutic categories. The largest are Medical Devices & Diagnostics (100.0%, 3 products).

Get Full Arkray Healthcare Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.